Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer

In the field of drug repurposing, the use of statins for treating dyslipidemia is considered promising in ovarian cancer treatment based on epidemiological studies and basic research findings. Biomarkers should be established to identify patients who will respond to statin treatment to achieve clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Yusuke, Takeda, Takashi, Kunitomi, Haruko, Chiwaki, Fumiko, Komatsu, Masayuki, Nagai, Shimpei, Nogami, Yuya, Tsuji, Kosuke, Masuda, Kenta, Ogiwara, Hideaki, Sasaki, Hiroki, Banno, Kouji, Aoki, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880614/
https://www.ncbi.nlm.nih.gov/pubmed/35215239
http://dx.doi.org/10.3390/ph15020124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880614/
https://www.ncbi.nlm.nih.gov/pubmed/35215239
http://dx.doi.org/10.3390/ph15020124

Ejemplares similares